News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President Of Clinical Development



8/4/2014 9:57:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RestorGenex Corporation (OTCQB: RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, announced today the appointment of Mark Weinberg MD, MBA as Senior Vice President of Clinical Development.

Before joining RestorGenex, Dr. Weinberg served as Vice President, Global Clinical Science at Astellas Pharma Global Development.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES